ImmunoPrecise Antibodies (NASDAQ:IPA) Rating Reiterated by Benchmark
ImmunoPrecise Antibodies (NASDAQ:IPA – Get Free Report)‘s stock had its “speculative buy” rating restated by investment analysts at Benchmark in a research note issued on Friday, Benzinga reports. They currently have a $5.00 target price on the stock. Benchmark’s target price indicates a potential upside of 257.14% from the company’s current price. ImmunoPrecise Antibodies Stock […]
More Stories
Disney to Pay $10 Million to Resolve Children’s Privacy Claims
By Bill Pan Disney will pay $10 million to settle allegations that it violated a federal children’s privacy law through...
Federal Reserve Minutes Reflect Ongoing Divergence Over Interest Rates
By Andrew Moran The Federal Reserve’s December meeting proved far more fractured than the final vote suggested, underscoring the persistent...
US, Allied Forces Have Killed or Captured More Than 2 Dozen ISIS Operatives in Syria
By Jacob Burg The United States and its partner forces have captured or killed nearly 25 operatives of the ISIS...
Beijing Invokes ‘Make America Great Again’ in Rare Bid to Ease US Tensions
By Michael Zhuang From Dec. 26 to 29, Chinese state media published a rare series of editorials striking a conciliatory...
Judge Blocks White House’s Attempt to Defund Consumer Watchdog Agency
By Jack Phillips A federal judge ruled Tuesday that the White House cannot lapse its funding of the Consumer Financial...
Top 11 Hottest News Anchors in the World of All Time
News anchors have become a part of global personality. They are no longer just people who read headlines. Now, viewers...